You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
pharma ai
About this tag
Pharma AI content on WindowsForum.com focuses on practical applications of artificial intelligence in the pharmaceutical industry, particularly in clinical trials and regulatory processes. Discussions highlight how AI accelerates site selection, patient recruitment, medical writing, and regulatory dossier assembly, cutting weeks to months from program timelines. A featured case study covers Almirall's deployment of Azure OpenAI, Azure AI Search, and Azure Databricks to index 400,000 documents spanning 50 years of research, enabling R&D teams to find experiments and protocols in seconds. These threads emphasize concrete operational gains rather than aspirational drug discovery, with an enterprise IT and Microsoft technology angle.
Pharmaceutical companies are quietly rolling out AI where it actually moves the needle: behind the lab bench, inside the paperwork, and across the administrative processes that previously swallowed months of calendar time and millions in budget. What the headlines call “AI drug discovery” is...
Pharmaceutical companies are reporting that artificial intelligence is already cutting measurable time from clinical trials and the heavy paperwork that surrounds regulatory submissions — not by inventing new drugs overnight, but by streamlining the “messy middle” of development: site selection...
Almirall’s R&D teams can now find the right experiment, protocol, or historical result in seconds instead of hours or days — a leap made possible by combining Azure OpenAI in Foundry Models, Azure AI Search, and Azure Databricks to index and query some 400,000 documents spanning more than 50...